Brain Tumor Reports
54

Volume 17 Number 9
September 2015


Home > Publications > Brain Tumor Reports > Volume 17, Year 2015 > Number 9, September*


CONTENTS



GLIOBLASTOMA
GLIOMAS
MEDULLOBLASTOMA
OLIGODENDROGLIOMA
PILOCYTIC ASTROCYTOMA





GLIOBLASTOMA



Anghileri E, Castiglione M, Nunziata R, Boffano C, Nazzi V, Acerbi F, Finocchiaro G, Eoli M.
Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.
Neurosurg Rev. 2015 Jul 28. doi:10.1007/s10143-015-0656-9 [Epub ahead of print].
Erratum in: Neurosurg Rev. 2015 Oct;38(4):773.
Source | Abstract | Full text | Similar articles




Carvalho BF, Fernandes AC, Almeida DS, Sampaio LV, Costa A, Caeiro C, Osório L, Castro L, Linhares P, Damasceno M, Vaz RC.
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study.
Oncol Res Treat. 2015;38(7-8):348-54. doi: 10.1159/000431236. Epub 2015 Jun 18.
Source | Abstract | Full text | Similar articles




Faivre G, Pentsova E, Demopoulos A, Taillibert S, Rosenblum M, Omuro A.
Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient.
Neurology. 2015 Aug 18;85(7):e57-61. doi: 10.1212/WNL.0000000000001848.
Source | Abstract | Full text | Similar articles




Franceschi E.
Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial.
Oncol Res Treat. 2015;38(7-8):345-6. doi: 10.1159/000435903. Epub 2015 Jul 1.
Source | Abstract | Full text | Similar articles




Gallego O.
Nonsurgical treatment of recurrent glioblastoma.
Curr Oncol. 2015 Aug;22(4):e273-81. doi: 10.3747/co.22.2436.
Source | Abstract | Full text | Similar articles




Kim SS, Harford JB, Pirollo KF, Chang EH.
Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Biochem Biophys Res Commun. 2015 Jun 24. pii: S0006-291X(15)30189-3. doi: 10.1016/j.bbrc.2015.06.137. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lok E, Hua V, Wong ET.
Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
Cancer Med. 2015 Aug 26. doi: 10.1002/cam4.519. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nava S, Lisini D, Pogliani S, Dossena M, Bersano A, Pellegatta S, Parati E, Finocchiaro G, Frigerio S.
Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
Stem Cells Transl Med. 2015 Aug 13. pii: sctm.2015-0091. doi: 10.5966/sctm.2015-0091. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Scorsetti M, Navarria P, Pessina F, Ascolese AM, D'Agostino G, Tomatis S, De Rose F, Villa E, Maggi G, Simonelli M, Clerici E, Soffietti R, Santoro A, Cozzi L, Bello L.
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.
BMC Cancer. 2015 Jun 30;15:486. doi: 10.1186/s12885-015-1488-2.
Source | Abstract | Full text | Similar articles




Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M.
Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Radiat Oncol. 2015 Aug 16;10:172. doi: 10.1186/s13014-015-0478-5.
Source | Abstract | Full text | Similar articles




Tai P, Dubey A, Salim M, Vu K, Koul R.
Diagnosis and Management of Spinal Metastasis of Glioblastoma.
Can J Neurol Sci. 2015 Aug 27:1-4. DOI: https://doi.org/10.1017/cjn.2015.285. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Thomas AA, Arevalo-Perez J, Kaley T, Lyo J, Peck KK, Shi W, Zhang Z, Young RJ.
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
J Neurooncol. 2015 Aug 15. doi:10.1007/s11060-015-1893-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tieu MT, Lovblom LE, McNamara MG, Mason W, Laperriere N, Millar BA, Ménard C, Kiehl TR, Perkins BA, Chung C.
Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide.
J Neurooncol. 2015 Aug;124(1):119-26. doi: 10.1007/s11060-015-1815-0. Epub 2015 May 27.
Source | Abstract | Full text | Similar articles





GLIOMAS



HIGH-GRADE GLIOMAS


Chastagner P, Devictor B, Geoerger B, Aerts I, Leblond P, Frappaz D, Gentet JC, Bracard S, André N.
Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.
Cancer Chemother Pharmacol. 2015 Aug;76(2):425-32. doi: 10.1007/s00280-015-2781-0. Epub 2015 Jun 27.
Source | Abstract | Full text | Similar articles




Díez Valle R, Tejada Solis S.
To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
CNS Oncol. 2015 Jul;4(4):265-72. doi: 10.2217/cns.15.10. Epub 2015 Jun 29.
Source | Abstract | Full text | Similar articles




Odia Y, Kreisl TN, Aregawi D, Innis EK, Fine HA.
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
J Neurooncol. 2015 Aug 19. doi:10.1007/s11060-015-1894-y [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Schwartz C, Romagna A, Thon N, Niyazi M, Watson J, Belka C, Tonn JC, Kreth FW, Nachbichler SB.
Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Acta Neurochir (Wien). 2015 Aug 23. doi:10.1007/s00701-015-2550-1 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Chamdine O, Broniscer A, Wu S, Gajjar A, Qaddoumi I.
Metastatic low-grade gliomas in children: 20 years' experience at St. Jude Children's Research Hospital.
Pediatr Blood Cancer. 2015 Aug 27. doi: 10.1002/pbc.25731. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Amayiri N, Al-Hussaini M, Swaidan M, Jaradat I, Qandeel M, Tabori U, Hawkins C, Musharbash A, Alsaad K, Bouffet E.
Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.
Childs Nerv Syst. 2015 Aug 21. doi:10.1007/s00381-015-2883-3 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Vivekanandan S, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze MN, Saran F, Thorp N, English M, Wheeler KA, Michalski A, Walker DA, Saunders D, Cowie F, Cameron A, Picton SV, Parashar D, Horan G, Williams MV.
The UK experience of a treatment strategy for pediatric metastatic medulloblastoma comprising intensive induction chemotherapy, hyperfractionated accelerated radiotherapy and response directed high dose myeloablative chemotherapy or maintenance chemotherapy (Milan strategy).
Pediatr Blood Cancer. 2015 Aug 14. doi: 10.1002/pbc.25663. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





OLIGODENDROGLIOMA



Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A.
Clinical management of grade III oligodendroglioma.
Cancer Manag Res. 2015 Jul 27;7:213-23. doi: 10.2147/CMAR.S56975. eCollection 2015.
Source | Abstract | Full text | Similar articles





PILOCYTIC ASTROCYTOMA



Ryu HH, Jung TY, Lee GJ, Lee KH, Jung SH, Jung S, Baek HJ.
Differences in the clinical courses of pediatric and adult pilocytic astrocytomas with progression: a single-institution study.
Childs Nerv Syst. 2015 Aug 21. doi:10.1007/s00381-015-2887-z [Epub ahead of print]
Source | Abstract | Full text | Similar articles